Omega-3 Fatty Acids for Post-Traumatic Stress Disorder

Omega-3s have intriguing early evidence in PTSD — including prevention studies after disasters — but the effect sizes are small and preliminary; trauma-focused therapy can genuinely resolve PTSD, and nothing supplemental should delay it.

Overview

Verdict

Mixed evidence

How It Works

DHA is integral to neuronal membrane function and fear-extinction learning (the process that fails in PTSD), while EPA's anti-inflammatory action may moderate the neuroinflammation observed in PTSD. Both plausibly support — not replace — trauma processing.

Dosing & Protocol

Typical dose

Recommended dose: 1,000-2,000 mg combined EPA+DHA daily with food
Expected timeframe: 8-12 weeks; adjunctive only

Protocol

form: High-EPA fish oil (EPA:DHA of at least 2:1)
duration: 12 weeks alongside trauma-focused therapy
co factor: Take with a fat-containing meal. Evidence is mixed: secondary-prevention trials after accidents gave inconsistent results, and no trial supports omega-3 as a primary PTSD treatment. Trauma-focused CBT, EMDR and SSRIs are the treatments with evidence.
titration: Increase to 2000 mg/day over two to four weeks; PTSD-adjacent trials used 1-3 g/day
starting dose: 1000 mg combined EPA+DHA daily with food

Evidence

What the studies say

Preliminary randomised trials, including studies giving omega-3s shortly after traumatic events, suggest reduced PTSD symptom development; other small trials show modest symptom reduction as adjuncts. Samples are small and results inconsistent — the evidence is early-stage. In stark contrast, trauma-focused CBT and EMDR have large, replicated effect sizes, with many patients resolving PTSD entirely. Alcohol, a common self-treatment, reliably worsens outcomes.

Omega-3 fatty acids for secondary prevention of posttraumatic stress disorder after accidental injury: an open-label pilot study

Score: 4/10

2010

observational

n=15

Matsuoka Y

In this open-label pilot, omega-3 supplementation started shortly after accidental injury was associated with lower PTSD symptom scores at follow-up than expected from the historical comparison, generating a hypothesis of secondary prevention.

View source

Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial

Score: 8/10

2015

rct

Matsuoka Y, Nishi D, Hamazaki K

Docosahexaenoic acid supplementation was not superior to placebo for the secondary prevention of PTSD symptoms at 3 months after severe accidental injury.

View source

Effects of omega-3 polyunsaturated fatty acids on psychophysiological symptoms of post-traumatic stress disorder in accident survivors

Score: 7/10

2016

rct

Matsumura K, Noguchi H, Nishi D

These findings suggest that post-trauma supplementation of omega-3 PUFAs might be effective for the secondary prevention of psychophysiological symptoms of PTSD.

View source

Safety

Caveats

Fishy reflux common. Mild blood-thinning at high doses. Never a substitute for trauma-focused therapy.

Less likely to help if

People not engaged in trauma-focused therapy, and those with complex PTSD and ongoing exposure to threat.

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.